Banks Get Hit… Plus Lawmakers Target Chinese Biotechs 9/10/24
CNBC's "Fast Money"
00:00
U.S. Energy Policy and Legislation Against Chinese Biotechs
This chapter explores U.S. energy legislation and its significant effects on Chinese biotech firms, with a focus on the Biosecure Act's implications for American pharmaceuticals. It also reviews the financial performance of companies like CORC in the context of an unstable oil market and highlights contrasting market trends for other firms.
Play episode from 30:40
Transcript
